Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
yi'anning
- Development stage
- Unknown
- Lead developer
- Beijing Hospital of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Yi'anning is a Traditional Chinese Medicine (TCM) formulation developed by the Beijing Hospital of Traditional Chinese Medicine, Capital Medical University. It is primarily indicated for the treatment of chronic fatigue syndrome (CFS), specifically for patients presenting with the TCM patterns of qi and blood deficiency and liver and kidney deficiency. The medication is formulated as a pill and has been evaluated in multi-center, randomized, double-blind, positive-controlled clinical trials in China. These studies often fall under the regulatory framework for the 'protection of traditional Chinese medicine varieties,' which is a process for established TCM products to maintain clinical and commercial status. Its therapeutic mechanism is based on TCM principles of systemic regulation, focusing on tonifying vital energy (qi) and blood while nourishing the liver and kidney systems to alleviate chronic exhaustion.
- Brand names
- Yi'anning
- Other names
- Yi'anning pillYining pillYi'anning wan
Beyond the preview
Go deeper on yi'anning.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on yi'anning.